CTI BioPharma Corp.
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$91,041,000 and profit margin reached -169%. Total operating expenses were $130,231,000.
Profit Margin
| 2013 | 34.67M | -42.74M | -123.26% |
|---|---|---|---|
| 2014 | 60.07M | -93.36M | -155.41% |
| 2015 | 16.11M | -119.42M | -741.02% |
| 2016 | 57.40M | -52.00M | -90.6% |
| 2017 | 25.14M | -40.67M | -161.74% |
| 2018 | 26.29M | -29.32M | -111.53% |
| 2019 | 3.34M | -42.31M | -1265.08% |
| 2020 | 0 | -52.95M | |
| 2021 | 0 | -99.63M | |
| 2022 | 53.94M | -91.04M | -168.76% |
CTIC Income Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 53.94M | 0 | 0 | 3.34M | 26.29M | 25.14M | 57.40M | 16.11M | 60.07M | 34.67M |
Cost of revenue | 3.51M | 161K | 4.2M | 0 | 879K | 364K | 1.37M | 1.94M | 895K | 137K |
Gross profit | 50.43M | -161K | -4.2M | 3.34M | 25.41M | 24.78M | 56.02M | 14.17M | 59.18M | 34.54M |
Operating exp. | ||||||||||
Research and development | 36.89M | 39.13M | 25.94M | 24.10M | 36.46M | 32.86M | 64.96M | 76.62M | 86.45M | 33.62M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 130.23M | 95.33M | 47.76M | 43.26M | 57.65M | 64.30M | 105.19M | 130.84M | 145.41M | 75.91M |
Operating income | -79.79M | -95.33M | -47.76M | -40.71M | -32.89M | -39.51M | -49.16M | -116.66M | -86.23M | -41.52M |
Other income (expenses), net | -13.19M | -2.57M | -4.68M | 688K | 3.54M | -1.31M | -3.79M | -4.09M | -7.99M | -2.02M |
Income before tax | -92.99M | -97.90M | -52.45M | -40.02M | -29.35M | -40.83M | -52.95M | -120.76M | -94.22M | -43.55M |
Income tax expense | -1.95M | 1.72M | 500K | 2.29M | 5.28M | 723K | -963K | -1.60M | -5.32M | -485K |
Net income | -91.04M | -99.63M | -52.95M | -42.31M | -29.32M | -40.67M | -52.00M | -119.42M | -93.36M | -42.74M |
Earnings per share | ||||||||||
Basic EPS | -0.79 | -1.11 | -0.74 | -0.73 | -0.52 | -1.12 | -1.86 | -4.26 | -6.29 | -3.74 |
Diluted EPS | -0.79 | -1.11 | -0.74 | -0.73 | -0.52 | -1.12 | -1.86 | -4.26 | -6.29 | -3.74 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |